Product Information
POLY HIST FORTE 10.5-10 MG TAB is a generic product labeled by Poly Pharmaceuticals, Inc., priced at $0.6637 per EA under NDC 50991062601. Its NADAC has been published 111 times since Sep 22, 2021.
Strength
10.5; 10 mg/1; mg/1
Manufacturer
Poly Pharmaceuticals, Inc.NDC
50991062601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
6/1/2019
Pharmacological Classes
Price Statistics
The NADAC for POLY HIST FORTE 10.5-10 MG TAB has been published 111 times since Sep 22, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6637 per EA |
|---|---|
| All-time high | $0.6642 (May 13, 2026) |
| All-time low | $0.6594 (Sep 22, 2021) |
| 52-week high | $0.6642 |
| 52-week low | $0.6617 |
| Median price | $0.6632 |
| Average price | $0.6629 |
| Largest weekly change | +0.6% (Sep 18, 2024) |
| Weeks tracked | 111 |
| Tracking since | Sep 22, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Doxylamine Succinate and Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Poly Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Doxylamine Succinate and Phenylephrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antihistamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of POLY HIST FORTE 10.5-10 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for POLY HIST FORTE 10.5-10 MG TAB, manufactured by Poly Pharmaceuticals, Inc., is $0.6637 per EA (NDC 50991062601), effective Sep 30, 2026.
How has the price of POLY HIST FORTE 10.5-10 MG TAB changed over time?
Over the history we have for it, the NADAC for POLY HIST FORTE 10.5-10 MG TAB has held within roughly two percent of its current level. It has been tracked across 111 weekly CMS publications since Sep 22, 2021.
What are the highest and lowest recorded NADAC prices for POLY HIST FORTE 10.5-10 MG TAB?
Since Sep 22, 2021, the NADAC for POLY HIST FORTE 10.5-10 MG TAB has ranged from a low of $0.6594 (Sep 22, 2021) to a high of $0.6642 (May 13, 2026), with a median of $0.6632 per EA.
Are there cheaper alternatives to POLY HIST FORTE 10.5-10 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of POLY HIST FORTE 10.5-10 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures POLY HIST FORTE 10.5-10 MG TAB?
POLY HIST FORTE 10.5-10 MG TAB (NDC 50991062601) is labeled by Poly Pharmaceuticals, Inc., and CMS classifies it as a generic product.